Trial Profile
Phase III trial of PBT-2 in Huntington disease
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 09 Jul 2019
Price :
$35
*
At a glance
- Drugs PBT 2 (Primary)
- Indications Huntington's disease
- Focus Registrational; Therapeutic Use
- Sponsors Alterity Therapeutics
- 04 Jun 2015 New trial record